Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-010940
Filing Date
2020-02-05
Accepted
2020-02-05 06:04:26
Documents
1
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 11015
  Complete submission text file 0001104659-20-010940.txt   12415
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4995 BRADENTON AVE, SUITE 240 DUBLIN OH 43017-3552
Business Address
Bruck Claudine (Reporting) CIK: 0001733680 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 20576282